Geniol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Geniol

Property Description
Active ingredient Acetylsalicylic Acid and Caffeine
Form Tablet (Oral Dosage Form)
Pharmacological class Combination Analgesic and Antipyretic
General purpose Symptomatic Pain and Fever Relief
Origin Synthetic Combination Product

What Type of Medicine is Geniol?

Geniol is defined as a proprietary medicinal product formulated as a fixed-dose pharmaceutical combination, designed for oral administration in the tablet form. It is primarily classified as a Combination Analgesic and Antipyretic, utilizing a synergistic blend of two distinct synthetic compounds. This classification is crucial: the Acetylsalicylic Acid (ASA) component is a recognized Nonsteroidal Anti-inflammatory Drug (NSAID), which is foundational to the preparation's systemic action on pain and fever. These fixed-dose combinations are developed to offer enhanced therapeutic results compared to monotherapies.

Geniol's Active Composition: Acetylsalicylic Acid and Caffeine

The formulation contains the active ingredients Acetylsalicylic Acid (ASA) and Caffeine (1,3,7-trimethylxanthine). The ASA provides the essential NSAID effect, while the Caffeine component acts as a Central Nervous System (CNS) Stimulant and adjuvant. Combination products containing Caffeine are characterized by improved analgesic efficacy compared to the pain reliever alone. This means the combination is intended to be more effective at managing discomfort than taking only the pain reliever by itself. The Caffeine component, a xanthine alkaloid, also contributes to the preparation's overall effect by acting as an adenosine receptor antagonist, a mechanism for enhancing alertness. The inclusion of Caffeine is a differentiating factor in this preparation, setting it apart from standard single-ingredient ASA products.

What is the General Therapeutic Purpose of Geniol?

The general therapeutic purpose of Geniol is to provide dual-action symptomatic treatment aimed at pain relief and fever regulation. This fixed-dose combination is commonly used for the temporary management of symptoms such as headache or general bodily discomfort. The synergy between the two active ingredients allows for complementary pharmacological actions, where the Analgesic, Antipyretic, and CNS Stimulant properties are leveraged. The preparation is designed to achieve a more rapid and sustained symptomatic response compared to the ASA component used in isolation.

Regulatory References

  1. MedlinePlus Drug Information on Aspirin

What side effects are possible with Geniol?

Possible Side Effects and Safety Information

Official regulatory documentation identifies several serious and common adverse reactions associated with Geniol therapy, requiring specific monitoring and precautions. The most common adverse reactions (ge 10% incidence) reported in clinical trials include headache, elevated liver transaminases, diarrhea, cough, influenza, sinusitis, and back pain.


Serious and Clinically Significant Adverse Reactions

Serious risks are primarily associated with the drug's mechanism of action and include:

  • Bradyarrhythmia and Atrioventricular (AV) Block: A significant decrease in heart rate is common after the first dose. Due to the risk of symptomatic bradycardia, a minimum six-hour observation period is required after the initial dose. This is a primary safety restriction for treatment initiation.
  • Infections: Geniol causes a dose-dependent reduction in peripheral lymphocyte count, increasing the risk of serious, sometimes fatal, infections. Treatment initiation is contraindicated in patients with active acute or chronic infections.
  • Macular Edema: Swelling in the back of the eye, which may cause blurred vision or decreased visual acuity. An ophthalmologic evaluation is mandatory before starting treatment and 3-4 months after initiation.
  • Liver Injury: Significant liver enzyme elevations and severe liver injury have been reported. Liver enzyme results must be obtained before and periodically during treatment. Discontinuation is warranted if severe injury is confirmed.
  • Fetal Risk: Based on animal studies, the drug may cause fetal harm. Effective contraception must be used by females of reproductive potential during treatment and for a specific period (at least two months) after stopping the medication.
  • Posterior Reversible Encephalopathy Syndrome (PRES) and Progressive Multifocal Leukoencephalopathy (PML) are rare but serious neurological conditions that require immediate discontinuation if suspected.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Geniol (Acetylsalicylic Acid and Caffeine) overdose strictly mandates specific emergency actions and describes documented clinical manifestations.

When Immediate Medical Help is Required

Any suspected or confirmed overdose requires that individuals seek immediate medical attention or contact emergency services without delay. Due to the potential for systemic complications, immediate hospitalization and continuous monitoring are required to manage toxicity and prevent severe outcomes.

Documented Overdose Manifestations

Overdose presents with manifestations related to both active components. Early signs of Acetylsalicylic Acid toxicity (Salicylism) officially include tinnitus (ringing in the ears), impaired hearing, nausea, vomiting, and dizziness. Excessive Caffeine exposure may contribute to central nervous system and cardiovascular effects such as tremor, restlessness, and tachycardia (rapid heartbeat).

Severe Outcomes and Official Management

Severe overdose scenarios are officially documented to escalate to life-threatening complications, including metabolic acidosis, seizures, coma, non-cardiogenic pulmonary edema, and acute renal impairment. Management measures described in regulatory texts involve procedures such as the administration of activated charcoal, urine alkalinization to promote drug elimination, and potentially hemodialysis for the most severe cases. Regulators note that no specific antidote is known for this type of poisoning.

Population-Specific Risk

Official labeling highlights that toxicity may be particularly severe in children, and the elderly population may exhibit subtle or non-specific symptoms, necessitating careful clinical vigilance.

Therapeutic Uses of Geniol

This combination analgesic is commonly used to help with symptomatic relief across domains characterized by acute, episodic discomfort and functional strain.

Managing Acute Pain Syndromes and Headache Episodes

The medication is commonly used to help address acute pain manifestations, with a particular focus on the relief of various headache disorders. This combination is applied to help manage acute migraine attacks and episodic tension-type headaches, and may be used when additional support beyond single-ingredient analgesics is desired. This includes easing the symptoms of tension-type headaches and assisting with the acute management of the distressing pain and associated manifestations of a migraine attack. It is also applied to manage other forms of temporary, self-limiting discomfort, such as toothache and menstrual cramps.

Supportive Relief for Systemic Aches and Fever

A central application is the provision of simultaneous relief from both feverishness and the generalized bodily aches that frequently accompany common illnesses like colds or influenza. This action addresses the widespread systemic discomfort and supports the moderation of elevated body temperature, and is relevant for easing the overall symptom load during symptomatic phases.

Indications Summary: The preparation is considered relevant for the symptomatic management of headache, fever, muscle aches, toothache, and menstrual cramps.

Addressing Pain Accompanied by Functional Fatigue

A key benefit of this formulation is its relevance in scenarios where pain is linked to drowsiness or functional fatigue. By combining pain relief with an adjuvant component, the medication may assist with managing the fatigue and lack of alertness that can be linked to painful episodes, and contributes to maintaining a sense of stability when symptoms interfere with routine activities.

“This preparation contributes to easing the overall symptom load and supports patients during difficult episodes involving acute manifestations of pain and fever.”


Quick Fact: Relief for Headache This combination is relevant in contexts involving episodic pain that may be accompanied by noticeable functional strain or fatigue.

Regulatory References

  1. NIH National Library of Medicine StatPearls Overview

Eligibility and Restrictions for Use

Eligibility Profile: Who can and cannot use Geniol?

The official eligibility criteria for Geniol, as documented in governmental regulatory sources, are strictly defined by age, pre-existing clinical status, and reproductive considerations.

Population Group Eligibility Status (Official Labeling)
Eligible Age Patients aged 10 years and older. Safety and effectiveness have not been established for pediatric patients under 10.
Contraindicated Groups Individuals with known hypersensitivity to Geniol or its excipients; patients with active acute or chronic infection; individuals with severe cardiac conditions, including a recent (within 6 months) history of myocardial infarction, unstable angina, or a baseline QTc interval ge500 msec.
Restricted Use Females of reproductive potential must have a negative pregnancy test before starting treatment and must use effective contraception during and for a specified time after therapy. Patients with severe hepatic impairment may require special monitoring, as use is not recommended at standard initial doses.

The medicine is formally contraindicated for patients with specific untreated heart rhythm defects (Mobitz Type II or third-degree AV block or sick sinus syndrome, unless they have a pacemaker). This official framework establishes precise boundaries on the patient population, excluding those with severe cardiovascular risks, active infections, or known allergies to the product, while mandating precautions for females who may become pregnant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This profile details the officially documented interaction patterns for Geniol (Acetylsalicylic Acid and Caffeine) as listed in regulatory documents.

Interaction-Related Restrictions and Constraints

Co-administration with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is advised to be avoided due to an increased risk of gastrointestinal bleeding and ulceration. The product is also restricted or contraindicated in patients with a hemorrhagic diathesis or active bleeding. The use of alcohol (Ethanol) is restricted due to the documented increased risk of gastrointestinal hemorrhage. Excessive intake of other caffeine-containing products must be limited to prevent symptoms associated with high systemic caffeine exposure.

Pharmacodynamic and Pharmacokinetic Interactions

Interactions are structured around additive effects on bleeding risk. The effects of Anticoagulants, Antiplatelet Agents, and SSRIs are potentiated, resulting in an increased risk of bleeding due to the Acetylsalicylic Acid (ASA) component. Furthermore, ASA antagonizes the effect of Uricosuric Agents (e.g., Probenecid) by reducing uric acid excretion. Certain quinolone antibiotics (CYP1A2 inhibitors), such as Ciprofloxacin, can cause a pharmacokinetic interaction that increases the plasma levels and delays the clearance of the Caffeine component. Conversely, Alkalinizing Agents (e.g., antacids) accelerate the renal clearance of the ASA metabolite.

Timing and Population Notes

A specific timing of administration may be required when co-administering with Ibuprofen to ensure the antiplatelet benefit of ASA is maintained. Caution is advised for patients with impaired renal or hepatic function, as slower clearance may increase interaction effects.

Mechanism of Action

The mechanism of Geniol is defined by the coordinated action of Acetylsalicylic Acid (ASA) and Caffeine across two distinct biological signaling systems, resulting in complementary physiological modulation of affected pathways.


Enzyme Inhibition and Thermoregulation

The ASA component acts through the irreversible inhibition of Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). This mechanism suppresses the production of Prostaglandin E2 ( PGE2), a mediator that contributes to the sensitization of nociceptive fibers and the elevation of the central thermoregulatory set-point. This interference produces a reduction in the transmission efficiency of nociceptive signals and resets the thermal regulation set-point.


Adenosine Receptor Antagonism

The Caffeine component functions as a competitive antagonist at Adenosine receptors ( A1 and A2 A) in both the central and peripheral nervous systems. By blocking the binding of inhibitory Adenosine, this action disinhibits neural activity, leading to increased CNS excitability and altered nociceptive transmission dynamics. This antagonism alters the dynamics of central and peripheral signaling pathways.


Pharmacodynamic Synergy

Caffeine provides an auxiliary effect, introducing its own central and peripheral antagonism of A2 A receptors, which complements ASA's peripheral modulation of nociceptive fiber excitability. This multi-target approach results in an altered threshold for nociceptive pathway modulation, engaging complementary mechanisms that influence signaling patterns across central and peripheral sites.

Dosage and Administration Information

The administration of Geniol follows specific established parameters. As a fixed-dose combination analgesic, its usage is limited to an oral route of administration using the provided tablet form.

The standard regimen for adults involves the ingestion of two tablets as a single unit at the onset of symptoms. Dosing may be repeated as needed, provided a mandatory minimum time interval is observed between administrations, typically every six hours. The maximum cumulative intake is limited to no more than eight tablets consumed within a 24-hour period.

Usage is defined as short-term and temporary. The medicine is not used for more than 10 days for pain or 3 days for fever without professional consultation. The tablets are to be swallowed whole with water and are not to be crushed or chewed. Although generally permitted with or without food, the preparation is usually restricted to the adult population.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Geniol

Evidence for Use in Episodic Tension-Type Headache

Research for the Acetylsalicylic Acid (ASA) and Caffeine combination includes multiple Randomized Controlled Trials (RCTs) and subsequent Meta-analyses. These studies were applied in research contexts involving fluctuating or unstable symptoms typical of episodic tension-type headache. The studies monitored outcomes related to physical discomfort, using measures such as pain intensity scales and the time required to achieve relief. Researchers examined outcomes in groups receiving the combination compared to single-ingredient ASA or a placebo.

Evidence for Use in Acute Migraine Attack

The combination was evaluated in studies focusing on acute migraine attacks, which are conditions involving periods of heightened symptoms. Researchers explored outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level during the acute episode. Key measurements included the rate at which participants achieved a pre-defined endpoint, such as the pain-free status recorded at two hours post-dose. Research describes measurements taken during the study period, including outcomes related to pain levels and patient-reported outcomes describing perceived discomfort from associated symptoms, such as light and sound sensitivity.

Duration of Relief and Extended Follow-up

The main research was studied for short-term symptom changes, which primarily focused on observing responses over defined time intervals following a single dose. Studies observed responses over defined time intervals, most often assessing outcomes over two to six hours, with some studies monitoring up to 24 hours for recurrence. The available research provides context but not individual predictions for the sustained effect beyond these initial periods. There is limited information for long-term outcomes because the study designs for acute symptomatic relief generally do not track patients over months or years.

Research Gaps and Areas of Uncertainty

Findings describe group patterns, not personal outcomes, and evidence highlights what is known—and what is still uncertain. One key limitation is that comparative evidence is lacking for direct, head-to-head trials against all other commercially available fixed-dose analgesic combinations. The main body of evidence focuses on the observation of short-term changes following a single dose for acute symptom management; thus, long-term effects are not fully established, and there is limited information regarding the patterns associated with very frequent, repeated administration.

Key Studies & References

  1. NIH National Library of Medicine StatPearls Overview: Analgesic Combinations for Headache
  2. MedlinePlus Monograph: Aspirin (Acetylsalicylic Acid)

Frequently Asked Questions (FAQ)

Common questions about Geniol (FAQ)

Q: Can Geniol affect sleep patterns?

According to the official product information, nervousness and sleeplessness are listed as potential side effects. These effects are generally attributed to the caffeine component in the medicine. Dizziness is also a reported side effect listed in regulatory documents.


Q: Does Geniol interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory documents explicitly warn against using Geniol with other medicines that contain acetaminophen or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen. Combining these products may increase the risk of adverse events. The product labeling emphasizes the importance of checking labels of other remedies for these ingredients.


Q: Can women who are pregnant or breastfeeding use Geniol?

Official guidelines indicate that a health professional should be consulted regarding use during pregnancy and breastfeeding. High doses of the Acetylsalicylic Acid (ASA) component are generally not recommended while breastfeeding due to a potential, though rare, risk of Reye’s Syndrome in the infant. Additionally, the label suggests that caffeine intake from the medicine requires consideration and limitation.


Q: How is Geniol generally packaged for patient use?

Official product labeling specifies the packaging and form of the medicine, which is supplied as an oral tablet. These documents mandate specific requirements for the packaging, often including child-resistant closures, to ensure safety and stability. This information is detailed in the 'How Supplied' section of regulatory documents.


Q: Is Geniol a generic or a brand name medicine?

The official regulatory information classifies Geniol as a proprietary medicinal product. Its specific status, whether brand-name or generic, is detailed in the prescribing information provided by the regulatory authorities.


Q: Does Geniol cause weight gain or weight loss?

According to the official regulatory documents, neither weight gain nor weight loss is listed among the commonly or seriously reported adverse reactions for this specific combination medicine. The documented side effect profile focuses on other types of reactions.


Q: Is it common to feel tired or dizzy when first taking Geniol?

Dizziness is listed as a reported side effect in the official product information. However, fatigue or general tiredness is not included among the commonly reported adverse reactions for Geniol.


Q: What food or drinks might interact with Geniol?

Official guidelines state that the use of alcohol is restricted while taking this medicine due to an increased risk of gastrointestinal bleeding. Additionally, excessive consumption of other caffeine-containing products is generally advised to be limited to limit the risk of overstimulation.


Q: Can I take Geniol with my daily vitamin supplements?

Regulatory documents do not typically list specific interactions with common daily vitamin supplements. However, official information generally suggests that patients inform their health professional about the use of all supplements and vitamins.


Q: What official documents say about Geniol and driving?

Because Geniol can cause central nervous system (CNS) side effects like dizziness or nervousness, warnings are typically provided in official documents. These warnings indicate that caution should be exercised when driving or operating heavy machinery until the effect of the medicine is known.


Q: Is Geniol considered habit-forming or addictive?

Based on its regulatory classification, this specific combination of Acetylsalicylic Acid and Caffeine is not listed as a controlled substance. Official documents indicate that the medicine is not considered to have abuse or dependence potential.


Q: What is the risk of stopping Geniol suddenly?

Regulatory labeling includes a specific warning regarding 'medication overuse headache.' This is a condition where using pain medication too frequently, such as for more than 10 days per month, may cause headaches to worsen or recur after the medicine is stopped.


Q: Are there different strengths of Geniol available?

Yes, the official prescribing information lists all available dosage strengths for Geniol tablets. These strengths are defined by the specific amounts of the active ingredients, Acetylsalicylic Acid and Caffeine, in each tablet.


Q: Can Geniol cause skin reactions or rashes?

Skin reactions, such as rashes or hives, are listed as potential side effects in the official safety information. These effects are often associated with the Acetylsalicylic Acid (aspirin) component. In rare instances, more severe allergic skin reactions have been reported.


Q: Why are people talking about Geniol causing [common vague symptom, e.g., 'stomach upset']?

Gastrointestinal adverse reactions are common side effects associated with Geniol. Official safety data reports that symptoms such as nausea, upset stomach, and dyspepsia (or indigestion) are commonly experienced by users.


Q: Does Geniol have any known interactions with herbal supplements?

Official documents generally advise caution regarding the co-administration of Geniol with herbal or dietary supplements. This is particularly important for supplements known to affect the risk of bleeding, such as garlic or ginkgo. Official guidance generally suggests consulting a health professional for advice.


Q: Does Geniol interact with hormonal birth control?

Regulatory documents do not typically list a known direct interaction with hormonal birth control methods. However, official information suggests discussing all concomitant medicines and supplements with a health professional.


Q: Does Geniol carry a specific black box warning from the FDA?

According to the FDA's regulatory information, the combination of Acetylsalicylic Acid and Caffeine in Geniol does not carry a specific Black Box Warning. Despite this, the labeling does include serious warnings and precautions regarding its use, particularly concerning fetal risk during pregnancy and potential adverse events.


Q: What scientific term describes how Geniol is processed in the body?

The scientific process that describes how Geniol moves through the body—including how it is absorbed, distributed, metabolized (broken down), and eliminated—is called Pharmacokinetics (often abbreviated as PK). This process is detailed in the Clinical Pharmacology section of the official documents.

How should Geniol be stored and disposed of?

Official Storage and Disposal Requirements

Genïol (Acetylsalicylic Acid and Caffeine) must be stored strictly according to the conditions defined in the official regulatory labeling. The medicine requires storage at controlled room temperature, which is defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original container, with the container tightly closed, and protected from moisture and light.

It is explicitly stated that the product must not be frozen.

For safety, the medication must be stored out of the sight and reach of children.

Disposal of unused or expired Genïol should preferentially be carried out through a formal drug take-back program. If a take-back program is unavailable, regulatory guidance permits mixing the product with an unappealing material (such as coffee grounds or dirt) in a sealed container for household trash disposal. The product must not be flushed down the toilet or disposed of in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Geniol found in:

A-Z Index: